They designed a type of tumor-targeting lipid-dendrimer-calcium-phosphate (TT-LDCP) NP to co-deliver immune checkpoint ligand PD-L1 siRNA and immunostimulatory IL-2 encoding plasmid DNA. The gene discussed is CD274; the disease is neoplasm.